Lagociclovir valactate is an orally administered prodrug that is converted in vivo to the active antiviral agent Lagociclovir. It is used in research as an anti-HBV compound, with applications in studying hepatitis B virus replication and evaluating antiviral efficacy in both cellular and animal models.